Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study.
Müller L, Mähringer-Kunz A, Auer TA, Fehrenbach U, Gebauer B, Haubold J, Theysohn JM, Kim MS, Kleesiek J, Diallo TD, Eisenblätter M, Bettinger D, Steinle V, Mayer P, Zopfs D, Pinto Dos Santos D, Kloeckner R. Müller L, et al. Among authors: bettinger d. Eur Radiol. 2023 Feb;33(2):1031-1039. doi: 10.1007/s00330-022-09069-8. Epub 2022 Aug 20. Eur Radiol. 2023. PMID: 35986768 Free PMC article.
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A; Liver-HERO Study Group. Ripoll C, et al. Trials. 2023 Apr 5;24(1):258. doi: 10.1186/s13063-023-07261-9. Trials. 2023. PMID: 37020315 Free PMC article. Clinical Trial.
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M. Bettinger D, et al. J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26. J Hepatol. 2021. PMID: 33508376
Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems.
Müller L, Hahn F, Auer TA, Fehrenbach U, Gebauer B, Haubold J, Zensen S, Kim MS, Eisenblätter M, Diallo TD, Bettinger D, Steinle V, Chang DH, Zopfs D, Pinto Dos Santos D, Kloeckner R. Müller L, et al. Among authors: bettinger d. Front Oncol. 2022 Feb 23;12:850454. doi: 10.3389/fonc.2022.850454. eCollection 2022. Front Oncol. 2022. PMID: 35280804 Free PMC article.
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma.
Mosconi C, O'Rourke J, Kloeckner R, Sturm L, Golfieri R, Celsa C, Fateen W, Odisio BC, Garanzini EM, Peck-Radosavljevic M, Borghi A, Ma YT, Stoehr F, Bettinger D, Giuffrida P, Aithal GP, Lin YM, Spreafico C, Giampalma E, Johnson P, Cucchetti A. Mosconi C, et al. Among authors: bettinger d. Cardiovasc Intervent Radiol. 2023 Apr;46(4):449-459. doi: 10.1007/s00270-023-03375-4. Epub 2023 Feb 27. Cardiovasc Intervent Radiol. 2023. PMID: 36849836
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.
Roehlen N, Stoehr F, Müller L, Luxenburger H, Gairing SJ, Reincke M, Schultheiss M, Berisha F, Weinmann A, Foerster F, Marquardt JU, Thimme R, Galle PR, Bettinger D, Kloeckner R. Roehlen N, et al. Among authors: bettinger d. Hepatol Commun. 2023 Sep 27;7(10):e0252. doi: 10.1097/HC9.0000000000000252. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37756031 Free PMC article.
176 results